Navigation Links
Late Breaking Data Released at ADA Showed that the Investigational,Use of Januvia and Metformin as Initial Combination Therapy,Provided Significant Glucose Lowering Efficacy over 54 Weeks in,Patients with Type 2 Diabetes

osage adjustment based upon renal function, assessment of renal function is recommended prior to initiation of JANUVIA and periodically thereafter. Creatinine clearance can be estimated from serum creatinine using the Cockcroft-Gault formula. (See Clinical Pharmacology (12.3).) 3 DOSAGE FORMS AND STRENGTHS -- 100 mg tablets are beige, round, film-coated tablets with "277" on one side. -- 50 mg tablets are light beige, round, film-coated tablets with "112" on one side. -- 25 mg tablets are pink, round, film-coated tablets with "221" on one side. 4 CONTRAINDICATIONS None. 5 WARNINGS AND PRECAUTIONS Use in Patients with Renal Insufficiency: A dosage adjustment is recommended in patients with moderate or severe renal insufficiency and in patients with ESRD requiring hemodialysis or peritoneal dialysis. (See Dosage and Administration (2.2); Clinical Pharmacology (12.3).) Use with Medications Known to Cause Hypoglycemia: In clinical trials of JANUVIA as monotherapy and JANUVIA as part of combination therapy with metformin or pioglitazone, rates of hypoglycemia reported with JANUVIA were similar to rates in patients taking placebo. The use of JANUVIA in combination with medications known to cause hypoglycemia, such as sulfonylureas or insulin, has not been adequately studied. 6 ADVERSE REACTIONS Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. 6.1 Clinical Trials Experience In controlled clinical studies as both monotherapy and combination therapy, the overall incidence of adverse reactions with JANUVIA was similar to that reported with placebo. Discontinuation of therapy due to clinical adverse reactions was also similar to placebo. Two placebo-controlled m
'"/>




Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32

Related medicine technology :

1. VeroScience Late-Breaking Abstract on Cycloset (A Quick Release Formulation of Bromocriptine Mesylate) Accepted for Poster Presentation at American Diabetes Association 67th Scientific Sessions
2. Pilot Phase 3 Results of NovaCardias KW-3902 for Acute Congestive Heart Failure Presented at Late-Breaking Session of Heart Failure Congress 2007
3. Breaking Multi-Center Study: Masimo SET Pulse Oximetry Technology Shown to Significantly Lower Instances of Severe Retinopathy of Prematurity in Extremely Low Birth Weight Infants
4. Bentley Late Breaking Abstract Accepted for Poster Presentation at American Diabetes Association Scientific Sessions
5. Cougar Biotechnology Presents Positive CB7630 Clinical Data at AACR Annual Meeting Late-Breaking Clinical Trials Session
6. Everest Data on Short- and Long-Term Use of Otsukas Investigational Novel Treatment, Tolvaptan, Published in Journal of the American Medical Association and Featured in ACCs Late Breaking Clinical Trials
7. Lupus Foundation of America Statement on Results for Clinical Study of CellCept Released by Aspreva Pharmaceutical Company
8. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
9. Amlodipine and Olmesartan Study Results Released;Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)
10. Amlodipine and Olmesartan Study Results Released; Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)
11. New Anti-Rejection Medication 6-Month Results for Heart Transplant Recipients to Be Released at International Heart and Lung Transplant Meeting
Post Your Comments:
(Date:7/29/2015)... WASHINGTON , July 29, 2015  The ... campaign to improve understanding of the advantages, limitations ... prenatal screening and other diagnostic tests for pregnant ... DGX ), the world,s leading provider of ... to support the initiative, through a grant. ...
(Date:7/29/2015)... Pulmatrix, Inc., (NASDAQ: PULM ) ... at 10:45 am EDT. As part of the ... will review Pulmatrix,s strategic plan and provide an ... based on their proprietary iSPERSE™ inhaled dry powder ... 2015 Time:    10:45 am EDT Link:      http://ir.pulmatrix.com ...
(Date:7/29/2015)... 29, 2015 According to a ... Active Pharmaceutical Ingredients (API) Market - Global Industry Analysis, ... " the global active pharmaceutical ingredients market was valued ... to reach USD 185.9 billion by 2020, expanding at ... 2014 to 2020. Full Research Report on ...
Breaking Medicine Technology:Quest Diagnostics Collaborates with Perinatal Quality Foundation on National Initiative to Advance Clinically Appropriate Noninvasive Prenatal Screening 2Quest Diagnostics Collaborates with Perinatal Quality Foundation on National Initiative to Advance Clinically Appropriate Noninvasive Prenatal Screening 3Quest Diagnostics Collaborates with Perinatal Quality Foundation on National Initiative to Advance Clinically Appropriate Noninvasive Prenatal Screening 4Pulmatrix to Webcast Investor Presentation and Provide Update on Pipeline of Inhaled Therapeutics August 6th 2Active Pharmaceutical Ingredients Market Expected to Reach USD 185.9 Billion Globally in 2020: Transparency Market Research 2Active Pharmaceutical Ingredients Market Expected to Reach USD 185.9 Billion Globally in 2020: Transparency Market Research 3Active Pharmaceutical Ingredients Market Expected to Reach USD 185.9 Billion Globally in 2020: Transparency Market Research 4Active Pharmaceutical Ingredients Market Expected to Reach USD 185.9 Billion Globally in 2020: Transparency Market Research 5
... Masimo (NASDAQ: MASI ) ... month,s issue of the peer-reviewed journal, Annals of ... measurements provide an "effective means for screening at-risk populations ... to invasive blood gas analysis.  The prospective diagnostic accuracy ...
... NEW YORK, April 21, 2011 Amgen (NASDAQ: ... and provided financial guidance for 2015 during a meeting with ... CEO opened the meeting by outlining key elements of the ... advance treatment of serious illness; Make significant and ...
Cached Medicine Technology:New Published Study Finds Masimo Noninvasive SpCO Effective for Screening Emergency Department Patients for Carbon Monoxide Poisoning 2New Published Study Finds Masimo Noninvasive SpCO Effective for Screening Emergency Department Patients for Carbon Monoxide Poisoning 3New Published Study Finds Masimo Noninvasive SpCO Effective for Screening Emergency Department Patients for Carbon Monoxide Poisoning 4New Published Study Finds Masimo Noninvasive SpCO Effective for Screening Emergency Department Patients for Carbon Monoxide Poisoning 5New Published Study Finds Masimo Noninvasive SpCO Effective for Screening Emergency Department Patients for Carbon Monoxide Poisoning 6Amgen Outlines Strategy, Growth Objectives and Capital Allocation Plans 2Amgen Outlines Strategy, Growth Objectives and Capital Allocation Plans 3Amgen Outlines Strategy, Growth Objectives and Capital Allocation Plans 4Amgen Outlines Strategy, Growth Objectives and Capital Allocation Plans 5Amgen Outlines Strategy, Growth Objectives and Capital Allocation Plans 6Amgen Outlines Strategy, Growth Objectives and Capital Allocation Plans 7Amgen Outlines Strategy, Growth Objectives and Capital Allocation Plans 8
(Date:7/29/2015)... ... July 29, 2015 , ... ... for a five-year period, expiring November 30, 2019, during its recent meeting. , ... an application demonstrating the program’s compliance with the NCCA’s Standards for the Accreditation ...
(Date:7/29/2015)... ... 29, 2015 , ... According to the Miami Herald on July ... mental health disorders. Acu-detox may begin taking off in the South Florida community as ... addiction. Although acupuncture is not a new practice, it is not widely used, but ...
(Date:7/29/2015)... ... July 29, 2015 , ... Orthopedic surgeons at Lourdes Medical Center of Burlington ... Cuff System, a new implant to treat a common source of shoulder pain and ... of additional tendon tissue, which could allow for faster healing and a decreased chance ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... We are privileged to announce that ... of USC as the ninth best ophthalmology hospital in the nation for 2015-2016. This marks ... American hospitals for ophthalmology. , “It is an honor to be included in the ...
(Date:7/29/2015)... ... July 29, 2015 , ... Inspired by ... in March, Steven W. Meier M.D., a prominent orthopedic surgeon and regenerative medicine ... with demonstrated financial need. , “We are thrilled for this opportunity to offer ...
Breaking Medicine News(10 mins):Health News:Commission for Case Manager Certification Receives Re-Accreditation of its CCM® credential from the National Commission for Certifying Agencies (NCCA) 2Health News:Commission for Case Manager Certification Receives Re-Accreditation of its CCM® credential from the National Commission for Certifying Agencies (NCCA) 3Health News:Miami Drug Rehab Introduces Acupuncture to Line of Holistic Healing for Addiction 2Health News:Miami Drug Rehab Introduces Acupuncture to Line of Holistic Healing for Addiction 3Health News:Lourdes Orthopedics First in NJ to Offer Bioinductive Implant for Rotator Cuff Repair 2Health News:Lourdes Orthopedics First in NJ to Offer Bioinductive Implant for Rotator Cuff Repair 3Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 2Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 3Health News:Orthopedic Surgeon Announces New Pro Bono Prolotherapy and Regenerative Medicine Clinic for Underserved Communities in Los Angeles 2
... Queensland is leading the way on research into ... medical use. , The National Institute of ... Professor Luis Vitetta to establish a NICM Collaborative ... Nutraceuticals and Herbal Medicine, which aims to support ...
... The American Red Cross,today launched Red Cross Racing, a ... and raise awareness of the need to give blood. ... fans are now able to join the Donor Rewards ... donation appointments,online. The site also offers frequent donors the ...
... Study of the Liver ... Annual Meeting -, SAN ... for the Study of the Liver,(EASL), the positive results of a Phase ... conducted by Dr. Edward,Gane, Associate Professor of Medicine, New Zealand Liver Transplant ...
... UK-based Association for International Cancer Research this week announced ... Dr Joe Tiralongo to further develop a potential anti-cancer ... , The grant will enable the team to ... in living cells. , Research leader Dr Joe Tiralongo ...
... surgeons to adjust suture tension during bridging procedures, ... SNN ; LSE: SN) Endoscopy Division today announced the ... to attach rotator cuff tissue to,bone in the shoulder. ... of North America (AANA) Spring Meeting, which began,today in ...
... Tool Helps Hospitals Assure That Their Computerized,Prescribing Systems ... in a National Hospital Quality Survey, WASHINGTON, ... Hospital Survey, The Leapfrog Group becomes the,first health ... hospitals to be,certain that their computerized medication prescribing ...
Cached Medicine News:Health News:UQ leads the way on complementary medicine research 2Health News:American Red Cross Launches New Interactive Website to Connect NASCAR Fans With Blood Donations 2Health News:Antipodean Pharmaceuticals Announces Results of Phase 2 Study of Lead Compound MitoQ(R) 2Health News:Antipodean Pharmaceuticals Announces Results of Phase 2 Study of Lead Compound MitoQ(R) 3Health News:$450,000 sweetener in colon cancer battle 2Health News:Smith & Nephew Endoscopy Launches the FOOTPRINT PK Suture Anchor for Shoulder Repair 2Health News:Smith & Nephew Endoscopy Launches the FOOTPRINT PK Suture Anchor for Shoulder Repair 3Health News:The Leapfrog Group Releases 2008 Hospital Survey Offering Consumers Greater Assurance of Safety 2Health News:The Leapfrog Group Releases 2008 Hospital Survey Offering Consumers Greater Assurance of Safety 3Health News:The Leapfrog Group Releases 2008 Hospital Survey Offering Consumers Greater Assurance of Safety 4
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: